| Drug Name | ( Adenuric ®(FEBUXOSTAT |
|---|---|
| Drug Class |
Anti-inflammation
|
| Risk minimization type |
Direct Healthcare Professional Communication DHPC
|
| Specialty (Theraputic area) |
Rheumatology
|
| Risk |
Higher rate of cardiovascular death in gout patients with established cardiovascular disease |
| Dear Healthcare provider letter DHPC |
|